Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-21

FDA Approved: DAPTOMYCIN — Original Application (Par Health USA, LLC)

View source ↗

Summary

FDA approves the original application for daptomycin by Par Health USA, LLC, authorizing its use as an antibiotic for certain serious infections. The approval c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Daptomycin (daptomycin)

Snippet

ORIG AP for DAPTOMYCIN (DAPTOMYCIN)